Publication:
Assessment of health-related quality of life in patients with advanced prostate cancer current state and future perspectives

Simple item page
dc.contributor.coauthorKretschmer, A.
dc.contributor.coauthorVan Den Bergh, R.C.N., Martini, A.
dc.contributor.coauthorMarra, G.
dc.contributor.coauthorValerio, M.
dc.contributor.coauthorTsaur, I.
dc.contributor.coauthorHeidegger, I.
dc.contributor.coauthorKasivisvanathan, V.
dc.contributor.coauthorKesch, C.
dc.contributor.coauthorPreisser, F.
dc.contributor.coauthorFankhauser, C.D.
dc.contributor.coauthorZattoni, F.
dc.contributor.coauthorCeci, F.
dc.contributor.coauthorOlivier, J.
dc.contributor.coauthorChiu, P.
dc.contributor.coauthorPuche-Sanz, I.
dc.contributor.coauthorThibault, C.
dc.contributor.coauthorGandaglia, G.
dc.contributor.coauthorYAU Prostate Cancer Working Group
dc.contributor.kuauthorTilki, Derya
dc.contributor.kuprofileOther
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoƧ University Hospital
dc.date.accessioned2024-11-09T12:19:05Z
dc.date.issued2022
dc.description.abstractWith the therapeutic landscape of advanced prostate cancer rapidly evolving and oncological benefits being shown for a plethora of new agents and indications, health-related quality of life (HRQOL)-associated evidence is still subpar. In the current comprehensive review, we discuss the importance of HRQOL for patients with advanced PC (metastatic hormone-sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castrationresistant prostate cancer (nmCRPC)), and present the most frequently used tools to evaluate HRQOL in recent randomized trials. Furthermore, we discuss the ease of use of these validated questionnaires for clinicians and try to focus on the suggested appropriate use in clinical practice, as well as potential strategies for improvement of HRQOL evaluation in these clinical scenarios of advanced prostate cancer.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume14
dc.formatpdf
dc.identifier.doi10.3390/cancers14010147
dc.identifier.eissn2072-6694
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03428
dc.identifier.linkhttps://doi.org/10.3390/cancers14010147
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85122300250
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1481
dc.identifier.wos751016000001
dc.keywordsEQ-5D
dc.keywordsFACT-P
dc.keywordsHealth-related quality of life
dc.keywordsMetastatic
dc.keywordsProstate cancer
dc.keywordsQLQ-C30
dc.languageEnglish
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10224
dc.sourceCancers
dc.subjectOncology
dc.titleAssessment of health-related quality of life in patients with advanced prostate cancer current state and future perspectives
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorTilki, Derya

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10224.pdf
Size:
415.24 KB
Format:
Adobe Portable Document Format
Download

Collections

Publications with Fulltext